Thus, SA‐EVs exacerbate SLE by hyperactivating NK cells via the TLR2‐MyD88‐NF‐κB pathway, leading to amplified systemic inflammation and aggravated LN. The gene discussed is TLR2; the disease is systemic lupus erythematosus.